0f83a254cd644be286f3c54cade8bed8

Upcoming Changes to the DOT Medical Certification Process

Fri, 04 Apr 2025 17:59:35 GMT

What Drivers and Motor Carriers Need to Know

Effective June 23, 2025, the Federal Motor Carrier Safety Administration (FMCSA) will implement a series of regulatory changes that modernize the process for certifying the medical fitness of commercial motor vehicle (CMV) drivers. These changes aim to enhance the efficiency, accuracy, and security of medical certification data while reducing the administrative burden on drivers and carriers. At the core of this transformation is the shift from paper-based certification to a centralized electronic reporting system.

FMCSA’s authority to implement these changes is rooted in 49 U.S.C. § 31133(a)(8) and § 31149(c)(1)(E). These statutes empower the agency to prescribe recordkeeping and reporting requirements, mandate electronic transmission of medical data, and implement rules that promote the health and safety of drivers operating CMVs in interstate commerce.

Although the Medical Examiner’s Certification Integration final rule was originally scheduled for implementation in 2021, the compliance deadline was extended to June 23, 2025. This gave the industry additional time to adjust systems and processes to accommodate these changes.

One of the most significant changes involves the elimination of paper Medical Examiner’s Certificates (Form MCSA-5876) as official proof of medical qualification for drivers who hold a Commercial Learner’s Permit (CLP) or Commercial Driver’s License (CDL). Historically, drivers were required to carry the original signed certificate and submit it to the State Driver Licensing Agencies (SDLAs) to update their CDLs (Commercial Driver’s License Information System) record.

Beginning June 23, 2025, that process will change. The Medical Examiner’s Certificate for CLP/CDL holders will be electronically transmitted by the ME through the National Registry to the SDLA. The SDLA will then update the driver’s CDLIS record accordingly. This electronically submitted data will become the only official record of the driver’s medical certification.

Drivers who request a paper copy may still receive one, but it will no longer be considered valid proof of certification for CLP/CDL holders. The only recognized verification will be the electronic record in the CDLIS.

Non-CDL drivers, however, are not affected by this shift. Medical Examiners will continue to provide them with the original paper Medical Examiner’s Certificate as their official documentation of medical fitness.

Reporting Requirements for Medical Examiners

Previously, Medical Examiners were required to report examination outcomes to FMCSA on a monthly basis. Under the new rule, MEs must report results by midnight of the next calendar day following each exam. This includes cases where a driver is found not medically qualified to operate a CMV.

To facilitate this change, MEs must now use FMCSA’s standard forms without alteration:

- Medical Examination Report Form (MCSA-5875)

- Medical Examiner’s Certificate (MCSA-5876)

- CMV Driver Medical Examination Results Form (MCSA-5850) — submitted electronically via the National Registry portal.

MEs who fail to comply with these form requirements or who do not report examination results in a timely manner may be subject to removal from the National Registry. The only minor modifications permitted include printing in black and white, resizing, and adding barcodes for internal office use—as long as the content remains legible and unchanged.

Additionally, if no exams are conducted in a calendar month, MEs must log in to their National Registry account and file a “No Exams” report by the last day of that month.

Accurate and complete demographic information is essential for the successful transmission of certification records. The ME is responsible for ensuring that the driver’s full name, date of birth, license number, and licensing state are recorded correctly. Inaccuracies will cause the National Registry system to reject the transmission, delaying the certification process. In some cases, drivers may need to return to the ME’s office to correct errors.

To mitigate these risks, FMCSA recommends that Medical Examiners retain a copy of each driver’s license to verify identifying details prior to submission.

For Drivers

For CLP/CDL drivers, the new system offers a more efficient way to ensure their medical certification status is current and accessible. However, it also means that drivers will need to schedule exams well in advance of their certificate’s expiration, as it may take three or more business days for the certification to be reflected in their CDLIS record.

Drivers must also be diligent about providing correct and up-to-date personal information. Even small errors could prevent certification data from being posted, potentially putting the driver at risk of being considered non-compliant.

For non-CDL drivers, the process remains largely unchanged. They will continue to receive and use the paper Medical Examiner’s Certificate as their valid proof of medical qualification.

For Motor Carriers

Motor carriers will no longer need to collect or maintain a paper copy of the Medical Examiner’s Certificate for CLP/CDL holders. Instead, they must check the driver’s MVR from the SDLA to confirm medical certification status.

This represents a shift in compliance procedures. Carriers will need to establish protocols for regularly verifying MVRs, especially during the hiring process and at the time of certificate renewal. If a driver’s certification has not been updated due to data errors or reporting delays, it could affect the carrier’s compliance standing and prevent the driver from operating a CMV.

For non-CDL drivers, the carrier must still verify that the Medical Examiner is certified and listed on the National Registry, and that the Medical Examiner’s Certificate is properly signed.

Read Final Rule here

DOT FMCSA Drug & Alcohol Testing Requirements

Fri, 28 Jun 2024 18:36:32 GMT

The Federal Motor Carrier Safety Administration (FMCSA) requires employers of commercial motor vehicle (CMV) drivers to implement a comprehensive drug and alcohol testing program. This is to ensure the safety of the transportation industry by preventing drug and alcohol misuse among drivers.

What Must Be Done?

Drug and Alcohol Testing Policy in place. Employers must develop a written drug and alcohol testing policy and distribute it to all employees. The policy should outline testing procedures, consequences of testing positive, and employee rights.

Pre-Employment Drug Testing. All new hires must undergo a drug test before performing any safety-sensitive functions. A negative result is required to proceed with employment.

Random program. Employees are selected randomly to undergo testing. This must be done on an ongoing basis throughout the year. The annual minimum drug and alcohol random testing rates are established within FMCSA for 2024: 50% Random Drug Testing Rate; 10% Random Alcohol Testing Rate.

Training. If you employ drivers then supervisors must receive at least 60 minutes of training on recognizing the signs of drug use and 60 minutes on recognizing the signs of alcohol misuse.

Types of Tests

Pre-Employment Testing. Conducted before a new employee begins performing safety-sensitive duties.
Random Testing. Employees are selected randomly to undergo testing. This must be done on an ongoing basis throughout the year.
Reasonable Suspicion Testing. Conducted when a trained supervisor observes signs of drug or alcohol misuse.
Post-accident testing. Required after certain accidents. Drug Testing: Within 32 hours. Alcohol Testing: Within 2 hours, if not document the reason and conduct within 8 hours.
Return-to-Duty Testing. Required after a driver has violated the drug and alcohol testing regulations and has completed the necessary treatment.
Follow-up testing. Conducted after a driver returns to duty following a violation. The number and frequency of tests are determined by a Substance Abuse Professional (SAP). (Note: Do not confuse this with a driver returning to work after vacation!)
Random Consortium

Small fleet motor carriers can join a consortium to manage the random testing pool, ensuring a sufficient number of drivers are tested. That means you will be in the same pool with other employers. The Consortium/Third-Party Administrator (C/TPA) selects drivers randomly, ensuring the process is unbiased.

If you have a larger fleet, employers have the option to establish their own stand-alone pools for random drug and alcohol testing. This means that the employer manages their own random testing program internally, selecting employees for testing in a manner that ensures each employee has an equal chance of being tested each time selections are made. The selection process must be computerized to ensure randomness and fairness. This approach provides greater control and customization over the testing process, allowing employers to tailor their random testing procedures to their specific operational needs and schedules. Stand-alone pools also ensure that testing is conducted consistently and in compliance with FMCSA regulations, reinforcing the commitment to a drug- and alcohol-free workplace. However, managing a stand-alone pool requires a robust administrative framework to handle the computerized selection process, maintain accurate records, and ensure compliance with all regulatory requirements. You may consider a hiring Drug and Alcohol Testing Management Service or Drug and Alcohol Testing software to make compliance easier.

Record Keeping

Employers must maintain records of all test results, both positive and negative.
Maintain Custody and Control Form Copies
Documentation of supervisor training on drug and alcohol misuse must be kept.
A copy of the written drug and alcohol policy and proof of distribution to employees.
Employers must prepare an annual summary, called MIS report, of the results of their drug and alcohol testing program and submit it to the FMCSA when required.

Oral Fluid in DOT Drug Testing

Tue, 02 May 2023 16:31:52 GMT

The Department of Transportation Federal Motor Carrier Safety Administration (FMCSA) published a final rule that authorizes employers to use oral fluid drug testing.

The Department of Transportation (DOT), Federal Aviation Administration (FAA), Federal Railroad Administration (FRA), Federal Motor Carrier Safety Administration (FMCSA), and Federal Transit Administration (FTA) released a final ruling on updated procedures for Transportation Workplace Drug and Alcohol Testing Programs to include the addition of Oral Fluid Specimen Testing for Drugs.

The rule amends the U.S. Department of Transportation's regulated industry drug testing program to include oral fluid testing. This additional methodology for drug testing will give employers a choice that will help combat employee cheating on urine drug tests and provide a less intrusive means of achieving the safety goals of the program.

Effective June 1, 2023.

Click the link to read the complete DOT rule

Steps in DOT FMCSA Drug Testing

Sat, 10 Dec 2022 21:50:17 GMT

Designated employer representative (DER) . An employee authorized by the employer to take immediate action(s) to remove employees from safety-sensitive duties, or cause employees to be removed from these covered duties, and to make required decisions in the testing and evaluation processes. The DER also receives test results and other communications for the employer, consistent with the requirements of this part. Service agents cannot act as DERs.

Chain of custody. The procedure used to document the handling of the urine specimen from the time the employee gives the specimen to the collector until the specimen is destroyed. This procedure uses the Federal Drug Testing Custody and Control Form (CCF) as approved by the Office of Management and Budget.

Collection site . A place selected by the employer where employees present themselves for the purpose of providing a urine specimen for a drug test.

Collector. A person who instructs and assists employees at a collection site, who receives and makes an initial inspection of the specimen provided by those employees, and who initiates and completes the CCF.

Consortium/Third-party administrator (C/TPA). A service agent that provides or coordinates the provision of a variety of drug and alcohol testing services to employers. C/TPAs typically perform administrative tasks concerning the operation of the employers' drug and alcohol testing programs. This term includes, but is not limited to, groups of employers who join together to administer, as a single entity, the DOT drug and alcohol testing programs of its members. C/TPAs are not “employers” for purposes of this part.

HHS. The Department of Health and Human Services or any designee of the Secretary, Department of Health and Human Services.

Laboratory. Any U.S. laboratory certified by HHS under the National Laboratory Certification Program as meeting the minimum standards of Subpart C of the HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs; or, in the case of foreign laboratories, a laboratory approved for participation by DOT under this part.

Medical Review Officer (MRO). A person who is a licensed physician and who is responsible for receiving and reviewing laboratory results generated by an employer's drug testing program and evaluating medical explanations for certain drug test results.

FMCSA DOT Reasonable Suspicion Training for Supervisor

Sat, 10 Dec 2022 21:38:33 GMT

Who has to comply?

Reasonable Suspicion Test - if a trained supervisor or trained company official believes or suspects an employee is under the influence of drugs or alcohol this type of test is required.

Supervisors must be trained in accordance with 49 CFR 382.603.

A reasonable suspicion test can be conducted only when a trained supervisor observes specific signs of alcohol and/or drug use.

CDL Driver’s supervisors are required by FMCSA 49 CFR 382.603 to take at least 60 minutes of training on the symptoms of alcohol abuse and another 60 minutes of training on the symptoms of controlled substance use.

The suspicion must be based on specific observations by the supervisor concerning the employee’s current appearance, behavior, speech, and smell that are usually associated with drug or alcohol use, and must be documented.

49 CFR 382.307

Click here to get your Reasonable Suspicion Supervisor Training Certificate

What is the Chain of Custody form in DOT drug testing?

Sat, 10 Dec 2022 21:22:28 GMT

Federal Drug Testing Custody and Control Form (CCF)

Federal Drug Testing Custody and Control Form (CCF) is used to document every urine collection required by the DOT drug testing program.
DOT urine collections must be documented on Federal CCF. CCF is a chain of 5 copies where each copy belongs to a different party.

1️⃣Copy 1 - Test Facility Copy (Laboratory Copy)
2️⃣Copy 2 – Medical Review Officer Copy
3️⃣Copy 3 – Collector Copy
4️⃣Copy 4 – Employer Copy
5️⃣Copy 5 – Donor Copy (Employee copy)

Click here to see an example of Federal Drug Testing Custody and Control Form (CCF)